Aquestive Therapeutics Inc (AQST)

May 22, 2026

AQST Stock Chart | AQUESTIVE THERAPEUTICS INC (NASDAQ:AQST) - ChartMill

May 22, 2026

May 20, 2026

Aquestive Therapeutics Charts Cautious, Liquid Path Forward - TipRanks

May 20, 2026

May 19, 2026

Aquestive Therapeutics Q1 earnings call highlights - MSN

May 19, 2026

May 18, 2026

Aquestive Therapeutics CEO sells $35,413 in company stock By Investing.com - Investing.com South Africa

May 18, 2026

May 18, 2026

Aquestive Therapeutics CEO sells $35,413 in company stock - Investing.com UK

May 18, 2026

May 17, 2026

PRN_FinancialWrapper - FinancialContent

May 17, 2026

May 16, 2026

Aquestive secures $150 million debt facility with Oaktree By Investing.com - Investing.com Nigeria

May 16, 2026

May 16, 2026

Aquestive targets Q3 FDA resubmission for Anaphylm and projects >$150M cash at launch - MSN

May 16, 2026

May 16, 2026

A Quick Look at Today's Ratings for Aquestive Therapeutics(AQST.US), With a Forecast Between $6 to $9 - Moomoo

May 16, 2026

May 16, 2026

Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Ardent Health Partners, Inc. (ARDT) - The Globe and Mail

May 16, 2026

May 15, 2026

Analysts Are Bullish on These Healthcare Stocks: Aquestive Therapeutics (AQST), Monopar Therapeutics Inc (MNPR) - The Globe and Mail

May 15, 2026

May 15, 2026

All News about Aquestive Therapeutics, Inc.Common Stock - The Chronicle-Journal

May 15, 2026

May 15, 2026

Lake Street Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $6 - Moomoo

May 15, 2026

May 15, 2026

Aquestive Says It’s on Track to Launch Anaphylm Studies for FDA - Allergic Living

May 15, 2026

May 15, 2026

Analysts Have Made A Financial Statement On Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) First-Quarter Report - Moomoo

May 15, 2026

May 15, 2026

The Aquestive Therapeutics, Inc. (NASDAQ:AQST) First-Quarter Results Are Out And Analysts Have Published New Forecasts - Yahoo Finance

May 15, 2026

May 15, 2026

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2026 Earnings Call Transcript - Insider Monkey

May 15, 2026

May 15, 2026

Citizens reiterates Aquestive stock rating on Anaphylm progress By Investing.com - Investing.com South Africa

May 15, 2026

May 15, 2026

Citizens reiterates Aquestive stock rating on Anaphylm progress - Investing.com

May 15, 2026

May 14, 2026

Aquestive Therapeutics Signals Momentum In Earnings Call - TipRanks

May 14, 2026

May 14, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 14, 2026

May 14, 2026

Aquestive Therapeutics, Inc. (AQST) Q1 2026 Earnings Call Transcript Summary - Moomoo

May 14, 2026

May 14, 2026

Aquestive Therapeutics, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:AQST) 2026-05-14 - Seeking Alpha

May 14, 2026

May 14, 2026

Aquestive Therapeutics Q1 Earnings Call Highlights - MarketBeat

May 14, 2026

May 14, 2026

Earnings call transcript: Aquestive’s Q1 2026 earnings beat forecasts, stock surges - Investing.com Nigeria

May 14, 2026

May 14, 2026

Aquestive Therapeutics Q1 2026 Earnings Call: Complete Transcript - Benzinga

May 14, 2026

May 13, 2026

Aquestive Therapeutics (AQST) reports Q1 loss, beats revenue estimates - MSN

May 13, 2026

May 13, 2026

Compared to estimates, Aquestive Therapeutics (AQST) Q1 earnings: A look at key metrics - MSN

May 13, 2026

May 13, 2026

AQST Achieves Strong Q1 Revenue and FDA Progress - GuruFocus

May 13, 2026

May 13, 2026

Aquestive Therapeutics earnings beat by $0.06, revenue topped estimates - Investing.com Canada

May 13, 2026

May 13, 2026

AQST Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

May 13, 2026

May 13, 2026

Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics - Yahoo Finance

May 13, 2026

May 13, 2026

Aquestive Therapeutics Incenters five-year term loan facility of up to $150 million on May 12, 2026SEC filing - marketscreener.com

May 13, 2026

May 13, 2026

Aquestive Secures New Oaktree Term Loan to Fund Anaphylm - TipRanks

May 13, 2026

May 13, 2026

Aquestive Therapeutics (AQST) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance

May 13, 2026

May 13, 2026

12 Health Care Stocks Moving In Wednesday's After-Market SessionAquestive Therapeutics (NASDAQ:AQST) - Benzinga

May 13, 2026

May 13, 2026

Aquestive Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

May 13, 2026

May 13, 2026

Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - Investing News Network

May 13, 2026

May 13, 2026

Aquestive Therapeutics: Q1 Earnings Snapshot - KTVB

May 13, 2026

May 13, 2026

Aquestive Therapeutics (AQST) trims Q1 loss and secures $150M Oaktree debt facility - Stock Titan

May 13, 2026

May 13, 2026

BRIEF-Aquestive Therapeutics, Inc. Q1 Revenue USD 14.446 Million Vs. IBES Estimate USD 10.9 Million - TradingView

May 13, 2026

May 13, 2026

Aquestive Therapeutics, Inc. Reaffirm Earnings Guidance for the Full Year 2026 - marketscreener.com

May 13, 2026

May 12, 2026

Aquestive Therapeutics Signs New $150 Million Debt Facility - Moomoo

May 12, 2026

May 12, 2026

Aquestive Therapeutics Secures $150M Refinancing Deal Ahead of Potential Anaphylm Launch - citybiz

May 12, 2026

May 12, 2026

Aquestive Therapeutics sees $150M debt refinancing - ROI-NJ

May 12, 2026

May 12, 2026

Aquestive secures $150 million debt facility with Oaktree - Investing.com UK

May 12, 2026

May 12, 2026

Aquestive Therapeutics Announces $150 Million Debt Refinancing to Support Anaphylm™ Launch if Approved by FDA - Quiver Quantitative

May 12, 2026

May 12, 2026

Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree - The Manila Times

May 12, 2026